Non-Small Cell Lung Cancer and Quality of Life (SILKE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by University of Turku.
Recruitment status was  Recruiting
Information provided by:
University of Turku Identifier:
First received: January 5, 2009
Last updated: January 6, 2009
Last verified: January 2009

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Non Small Cell Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Treatment of Non-Small Cell Lung Cancer -Effects on Quality of Life and Symptom Control

Resource links provided by NLM:

Further study details as provided by University of Turku:

Biospecimen Retention:   Samples With DNA

whole blood

Estimated Enrollment: 200
Study Start Date: August 2008
Estimated Study Completion Date: September 2011
Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Non-small cell lung cancer patients


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The patients treated in the clinic of respiratory medicine in Turku, Finland


Inclusion Criteria:

  • Patients with verified NSCLC
  • after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
  • Finnish speaking patients
  • aged 18 years or more
  • Written informed consent has to be signed

Exclusion Criteria:

  • Patients not consenting to participate in the study
  • patients not able to communicate sufficiently
  • cancer type is other than non-small-cell lung cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00818402

Contact: Maria Silvoniemi, MD +358 50 3442175

Turku University Hospital, the Clinic of Resperatory Medicine Recruiting
Turku, Finland, 20521
Contact: Maria Silvoniemi   
Sponsors and Collaborators
University of Turku
  More Information

No publications provided

Responsible Party: MD Maria Silvoniemi, University of Turku Identifier: NCT00818402     History of Changes
Other Study ID Numbers: SILKE-ETMK:47/180/2008
Study First Received: January 5, 2009
Last Updated: January 6, 2009
Health Authority: Finland: Ethics Committee

Keywords provided by University of Turku:
Quality of life

Additional relevant MeSH terms:
Carcinoma, Non-Small-Cell Lung
Bronchial Neoplasms
Carcinoma, Bronchogenic
Lung Diseases
Lung Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms processed this record on March 26, 2015